{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:14:25Z","timestamp":1794543265437,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cbpa.2024.102538","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T01:05:52Z","timestamp":1729127152000},"page":"102538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Drug discovery targeting Nav1.8: Structural insights and therapeutic potential"],"prefix":"10.1016","volume":"83","author":[{"given":"Huan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2024.102538_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1113\/jphysiol.1952.sp004764","article-title":"A\u00a0quantitative description of membrane current and its application to conduction and excitation in nerve","volume":"117","author":"Hodgkin","year":"1952","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.cbpa.2024.102538_sref2","article-title":"Structural biology and molecular pharmacology of voltage-gated ion channels","author":"Huang","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cbpa.2024.102538_bib3","series-title":"Ion channels of excitable membranes","author":"Hille","year":"2001"},{"key":"10.1016\/j.cbpa.2024.102538_bib4","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S0021-9258(17)43460-0","article-title":"The sodium channel from rat brain. Purification and subunit composition","volume":"259","author":"Hartshorne","year":"1984","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cbpa.2024.102538_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2023.2287832","article-title":"A\u00a0structural atlas of druggable sites on Na(v) channels","volume":"18","author":"Li","year":"2024","journal-title":"Channels"},{"key":"10.1016\/j.cbpa.2024.102538_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/gb-2003-4-3-207","article-title":"Overview of the voltage-gated sodium channel family","volume":"4","author":"Yu","year":"2003","journal-title":"Genome Biol"},{"key":"10.1016\/j.cbpa.2024.102538_bib7","doi-asserted-by":"crossref","first-page":"RC43","DOI":"10.1523\/JNEUROSCI.19-24-j0001.1999","article-title":"A\u00a0novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons","volume":"19","author":"Cummins","year":"1999","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cbpa.2024.102538_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/379257a0","article-title":"A\u00a0tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons","volume":"379","author":"Akopian","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2024.102538_bib9","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1073\/pnas.95.15.8963","article-title":"NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy","volume":"95","author":"Dib-Hajj","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102538_sref10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-020-00415-2","article-title":"Status of peripheral sodium channel blockers for non-addictive pain treatment","volume":"16","author":"Alsaloum","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.cbpa.2024.102538_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature05413","article-title":"An SCN9A channelopathy causes congenital inability to experience pain","volume":"444","author":"Cox","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2024.102538_bib12","doi-asserted-by":"crossref","first-page":"8232","DOI":"10.1523\/JNEUROSCI.2695-04.2004","article-title":"Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy","volume":"24","author":"Cummins","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cbpa.2024.102538_bib13","doi-asserted-by":"crossref","first-page":"12706","DOI":"10.1073\/pnas.0404915101","article-title":"Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain","volume":"101","author":"Nassar","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102538_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jmg.2003.012153","article-title":"Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia","volume":"41","author":"Yang","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.cbpa.2024.102538_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/jn.2001.86.2.629","article-title":"Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons","volume":"86","author":"Renganathan","year":"2001","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.cbpa.2024.102538_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2006.121483","article-title":"Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons","volume":"579","author":"Rush","year":"2007","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.cbpa.2024.102538_bib17","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1523\/JNEUROSCI.23-32-10338.2003","article-title":"Role of tetrodotoxin-resistant Na+ current slow inactivation in adaptation of action potential firing in small-diameter dorsal root ganglion neurons","volume":"23","author":"Blair","year":"2003","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cbpa.2024.102538_bib18","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1073\/pnas.0611364104","article-title":"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat","volume":"104","author":"Jarvis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102538_bib19","unstructured":"Pfizer: Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain. https:\/\/clinicaltrials.gov\/show\/NCT01512160 2013."},{"key":"10.1016\/j.cbpa.2024.102538_bib20","unstructured":"Pfizer: Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects. https:\/\/clinicaltrials.gov\/study\/NCT01747941?term=PF-06305591&rank=2 2013."},{"key":"10.1016\/j.cbpa.2024.102538_bib21","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/pm\/pnab032","article-title":"A\u00a0phase 1, randomized, double-blind, placebo-controlled, crossover study to evaluate the pharmacodynamic effects of VX-150, a highly selective NaV1.8 inhibitor, in healthy male adults","volume":"22","author":"Hijma","year":"2021","journal-title":"Pain Med"},{"key":"10.1016\/j.cbpa.2024.102538_bib22","series-title":"Treatment of neurological and neurodevelopmental diseases and disorders associated with aberrant ion channel expression and activity","author":"Maher","year":"2018"},{"key":"10.1016\/j.cbpa.2024.102538_bib23","unstructured":"Vertex: A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy. https:\/\/clinicaltrials.gov\/show\/NCT03304522 2019."},{"key":"10.1016\/j.cbpa.2024.102538_bib24","unstructured":"Vertex: A Single-arm Study to Evaluate Safety and Effectiveness of VX-548 for Acute Pain. https:\/\/clinicaltrials.gov\/study\/NCT05661734 2024."},{"key":"10.1016\/j.cbpa.2024.102538_bib25","unstructured":"Vertex: Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy. https:\/\/clinicaltrials.gov\/study\/NCT05553366 2024."},{"key":"10.1016\/j.cbpa.2024.102538_bib50","series-title":"Vertex: Evaluation of efficacy and safety of VX-548 for acute pain after an abdominoplasty","year":"2024"},{"key":"10.1016\/j.cbpa.2024.102538_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa2209870","article-title":"Selective inhibition of Na(V)1.8 with VX-548 for acute pain","volume":"389","author":"Jones","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cbpa.2024.102538_bib28","unstructured":"Vertex: Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN). https:\/\/clinicaltrials.gov\/study\/NCT05660538 2024."},{"key":"10.1016\/j.cbpa.2024.102538_bib29","unstructured":"Vertex: Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR). https:\/\/clinicaltrials.gov\/study\/NCT06176196 2024."},{"key":"10.1016\/j.cbpa.2024.102538_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-021-03699-6","article-title":"Structure of human Ca(v)2.2 channel blocked by the painkiller ziconotide","volume":"596","author":"Gao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2024.102538_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(10)60354-6","article-title":"Ziconotide for treatment of severe chronic pain","volume":"375","author":"Schmidtko","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cbpa.2024.102538_bib32","doi-asserted-by":"crossref","first-page":"P1394","DOI":"10.1016\/j.chembiol.2024.07.008","article-title":"A\u00a0versatile residue numbering scheme for Na(v) and Ca(v) channels","volume":"31","author":"Jin","year":"2024","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.cbpa.2024.102538_sref33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208211119","article-title":"Structural basis for high-voltage activation and subtype-specific inhibition of human Na(v)1.8","volume":"119","author":"Huang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102538_sref35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309773120","article-title":"Dual-pocket inhibition of Na(v) channels by the antiepileptic drug lamotrigine","volume":"120","author":"Huang","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102538_bib49","series-title":"Schr\u00f6dinger release 2018-1","year":"2018"},{"key":"10.1016\/j.cbpa.2024.102538_bib34","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1111\/bph.13092","article-title":"A\u00a0novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability","volume":"172","author":"Payne","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cbpa.2024.102538_bib36","article-title":"Structural basis for pore blockade of the human cardiac sodium channel Nav1.5 by tetrodotoxin and quinidine","author":"Li","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.cbpa.2024.102538_bib37","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1021\/bi301256s","article-title":"Distinct disulfide isomers of mu-conotoxins KIIIA and KIIIB block voltage-gated sodium channels","volume":"51","author":"Khoo","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbpa.2024.102538_bib38","doi-asserted-by":"crossref","first-page":"30699","DOI":"10.1074\/jbc.M704616200","article-title":"Structure\/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels","volume":"282","author":"Zhang","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cbpa.2024.102538_bib39","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.aaw2999","article-title":"Molecular basis for pore blockade of human Na(+) channel Na(v)1.2 by the mu-conotoxin KIIIA","volume":"363","author":"Pan","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2024.102538_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxicon.2017.02.013","article-title":"A\u00a0novel mu-conotoxin from worm-hunting Conus tessulatus that selectively inhibit rat TTX-resistant sodium currents","volume":"130","author":"Yang","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.cbpa.2024.102538_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.toxicon.2020.07.024","article-title":"mu-conotoxin TsIIIA, a peptide inhibitor of human voltage-gated sodium channel hNa(v)1.8","volume":"186","author":"Yang","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.cbpa.2024.102538_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209164119","article-title":"Unwinding and spiral sliding of S4 and domain rotation of VSD during the electromechanical coupling in Na(v)1.7","volume":"119","author":"Huang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102538_bib43","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-023-38942-3","article-title":"Structural mapping of Na(v)1.7 antagonists","volume":"14","author":"Wu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2024.102538_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/molpharm.123.000789","article-title":"Pharmacologic characterization of LTGO-33, a selective small molecule inhibitor of the voltage-gated sodium channel Na(V)1.8 with a unique mechanism of action","volume":"105","author":"Gilchrist","year":"2024","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cbpa.2024.102538_bib45","doi-asserted-by":"crossref","first-page":"25774","DOI":"10.1074\/jbc.M313002200","article-title":"Structures of muO-conotoxins from Conus marmoreus. I nhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons","volume":"279","author":"Daly","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cbpa.2024.102538_bib46","doi-asserted-by":"crossref","first-page":"17030","DOI":"10.1073\/pnas.0601819103","article-title":"muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits","volume":"103","author":"Ekberg","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102538_bib47","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bcp.2012.05.008","article-title":"Isolation, characterization and total regioselective synthesis of the novel muO-conotoxin MfVIA from Conus magnificus that targets voltage-gated sodium channels","volume":"84","author":"Vetter","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cbpa.2024.102538_bib48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpneuro0113","article-title":"Mechanisms of disease: neuropathic pain--a\u00a0clinical perspective","volume":"2","author":"Baron","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.cbpa.2024.102538_sref26","first-page":"162","article-title":"Vertex's non-opioid painkiller passes phase III tests","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat Rev Drug Discov"}],"updated-by":[{"DOI":"10.1016\/j.cbpa.2024.102546","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593124001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593124001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:26:17Z","timestamp":1732785977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593124001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"alternative-id":["S1367593124001145"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2024.102538","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug discovery targeting Nav1.8: Structural insights and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2024.102538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102538"}}